“…The in‐vitro metabolism studies were performed utilizing human liver S9 fractions (XenoTech, LLC, Lenexa, KS, USA) for both phase I and phase II metabolism. The incubation was performed as described and all analyses were performed in triplicate (Gautam, Bathena, Chen, Natarajan, & Alnouti, ; Gautam, Thakare, Rana, Natarajan, & Alnouti, ; Krishnaiah et al, ). The in vitro metabolic stability of MOX was determined using human liver S9 fractions following standard protocols.…”